Metro Minnesota Community Oncology — Minneapolis, Minnesota

Metro Minnesota Community Oncology is a clinical research site located in Minneapolis, Minnesota, United States 55416.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Metro Minnesota Community Oncology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Grade 2 Glioma, Residual Glioma, Recurrent Glioma.

Sponsors: Institut de Recherches Internationales Servier.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro Minnesota Community Oncology?

Metro Minnesota Community Oncology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro Minnesota Community Oncology conducted?

Metro Minnesota Community Oncology has 1 clinical trials on record, with 1 currently active. Their work covers Grade 2 Glioma, Residual Glioma, Recurrent Glioma.

Is Metro Minnesota Community Oncology accredited by Crixeo Health?

Metro Minnesota Community Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro Minnesota Community Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.